Leave no mutation behind
46 followers 0 articles/week
Perlara Events – January 2019

Last June, we launched Perlara On the Go, a monthly post updating you on upcoming events – be they conferences that Perlara team members are participating in, events that may be of interest to the life sciences community at large, or recaps of past events. Read on for Perlara On the Go January 2019!   Upcoming Events 37th annual J.P. Morgan Healthcare...

Fri Jan 4, 2019 20:50
Conducting a GNAO1 yeast screen

As discussed in a previous post, we are currently working on a GNAO1 PerlQuest collaboration with the Undiagnosed Diseases Network (UDN) and Harvard Medical School. GNAO1 is a gene that encodes for the alpha subunit of a G protein, and mutations in this gene lead a range of neurodevelopmental disorders. In yeast, the GNAO1 ortholog is GPA1, and in our...

Fri Dec 21, 2018 20:17
Modeling Pompe disease in flies

Here at Perlara we are excited to announce our probe into Pompe disease which, along with Cori disease, comprise our glycogen storage disease PerlQuest. For this project we will be collaborating with the Warren Center at the University of Notre Dame. Our goal is to develop an accurate Pompe disease fly model, and to test a select group of candidate...

Sat Dec 15, 2018 00:33
Last month in tweets – November 2018

Hello readers! Last month, we resurrected the old Perlara tradition of recapping the previous month through tweets. It’s a monthly roundup of what happened at Perlara – new partnerships, staff news, events that Perlara team members attended, and anything else that was tweet-worthy. Catch up on November 2018 in tweets!    November 2018 in tweets: ...

Thu Dec 6, 2018 21:17
Perlara Events – December 2018

In June, we launched Perlara On the Go, a monthly post updating you on upcoming events – be they conferences that Perlara team members are participating in, events that may be of interest to the life sciences community at large, or recaps of past events. Read on for Perlara On the Go December 2018!   Upcoming Events Curing Pancreatitis – It’s...

Thu Dec 6, 2018 21:17
Developing an NPA patient fibroblast screen

Niemann-Pick Type A (NPA) affects about 1 in 250,000 individuals, with a higher frequency in individuals of Ashkenazi Jewish descent, where it’s about 1 in 40,000. NPA is caused by a mutation in the SMPD1 gene, a gene encoding acid sphingomyelinase which, when mutated, stops the conversion of sphingomyelin into ceramide. This causes an accumulation...

Fri Nov 30, 2018 05:18

Build your own newsfeed

Ready to give it a go?
Start a 14-day trial, no credit card required.

Create account